Tags

Type your tag names separated by a space and hit enter

Role of CGRP and GABA in the hypotensive effect of intrathecally administered anandamide to anesthetized rats.
Eur J Pharmacol. 2006 Feb 17; 532(1-2):88-98.EJ

Abstract

In urethane-anesthetized rats the intrathecal (i.t.) injection of 100 nmol anandamide produced a hypotensive effect (-19.3+/-1.6 mm Hg; n=6) that was mimicked by i.t. administration of 0.25 nmol calcitonin gene-related peptide (CGRP; -26.2+/-1.8 mm Hg, n=4). Both effects were antagonized either by the CGRP receptor antagonist CGRP(8-37) (5 nmol; i.t.) or by the gamma-aminobutyric acid (GABA)(A) receptor antagonist bicuculline (8.8 nmol, i.t) or by the GABA(B) receptor antagonist 2-hydroxy saclofen (110 nmol; i.t.). On the contrary, blockade of spinal CGRP receptors by CGRP(8-37) did not modify the hypotensive response to either the GABA(A)-receptor agonist muscimol (8.8 nmol; i.t.) or the GABA(B)-receptor agonist baclofen (100 nmol; i.t). This result suggests a unidirectional effect of CGRP on the GABAergic system. The response to anandamide remained unaltered after acute inhibition of nitric oxide (NO) synthase activity by either i.t. (1 micromol) or i.v. (10 mg/kg) injection of N(G)-nitro-L-arginine methyl ester (L-NAME), but increased significantly after long-term L-NAME administration (70 mg/kg/day; four weeks; p.o.), thus suggesting compensatory changes in cardiovascular homeostasis. It is proposed that the hypotensive effect of anandamide in urethane-anesthetized rats could involve the release of CGRP followed by the release of GABA in the spinal cord. NO does not appear to have a direct participation in the spinal mechanisms involved in the decrease of the blood pressure caused by anandamide.

Authors+Show Affiliations

Cátedra de Farmacología, Facultad de Farmacia y Bioquímica (Universidad de Buenos Aires), Junín 956, 5o piso, 1113 Buenos Aires, Argentina.No affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

16472800

Citation

García, María del Carmen, et al. "Role of CGRP and GABA in the Hypotensive Effect of Intrathecally Administered Anandamide to Anesthetized Rats." European Journal of Pharmacology, vol. 532, no. 1-2, 2006, pp. 88-98.
García Mdel C, Adler-Graschinsky E, Celuch SM. Role of CGRP and GABA in the hypotensive effect of intrathecally administered anandamide to anesthetized rats. Eur J Pharmacol. 2006;532(1-2):88-98.
García, M. d. e. l. . C., Adler-Graschinsky, E., & Celuch, S. M. (2006). Role of CGRP and GABA in the hypotensive effect of intrathecally administered anandamide to anesthetized rats. European Journal of Pharmacology, 532(1-2), 88-98.
García Mdel C, Adler-Graschinsky E, Celuch SM. Role of CGRP and GABA in the Hypotensive Effect of Intrathecally Administered Anandamide to Anesthetized Rats. Eur J Pharmacol. 2006 Feb 17;532(1-2):88-98. PubMed PMID: 16472800.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Role of CGRP and GABA in the hypotensive effect of intrathecally administered anandamide to anesthetized rats. AU - García,María del Carmen, AU - Adler-Graschinsky,Edda, AU - Celuch,Stella Maris, Y1 - 2006/02/10/ PY - 2005/03/31/received PY - 2005/12/14/revised PY - 2005/12/16/accepted PY - 2006/2/14/pubmed PY - 2006/6/3/medline PY - 2006/2/14/entrez SP - 88 EP - 98 JF - European journal of pharmacology JO - Eur J Pharmacol VL - 532 IS - 1-2 N2 - In urethane-anesthetized rats the intrathecal (i.t.) injection of 100 nmol anandamide produced a hypotensive effect (-19.3+/-1.6 mm Hg; n=6) that was mimicked by i.t. administration of 0.25 nmol calcitonin gene-related peptide (CGRP; -26.2+/-1.8 mm Hg, n=4). Both effects were antagonized either by the CGRP receptor antagonist CGRP(8-37) (5 nmol; i.t.) or by the gamma-aminobutyric acid (GABA)(A) receptor antagonist bicuculline (8.8 nmol, i.t) or by the GABA(B) receptor antagonist 2-hydroxy saclofen (110 nmol; i.t.). On the contrary, blockade of spinal CGRP receptors by CGRP(8-37) did not modify the hypotensive response to either the GABA(A)-receptor agonist muscimol (8.8 nmol; i.t.) or the GABA(B)-receptor agonist baclofen (100 nmol; i.t). This result suggests a unidirectional effect of CGRP on the GABAergic system. The response to anandamide remained unaltered after acute inhibition of nitric oxide (NO) synthase activity by either i.t. (1 micromol) or i.v. (10 mg/kg) injection of N(G)-nitro-L-arginine methyl ester (L-NAME), but increased significantly after long-term L-NAME administration (70 mg/kg/day; four weeks; p.o.), thus suggesting compensatory changes in cardiovascular homeostasis. It is proposed that the hypotensive effect of anandamide in urethane-anesthetized rats could involve the release of CGRP followed by the release of GABA in the spinal cord. NO does not appear to have a direct participation in the spinal mechanisms involved in the decrease of the blood pressure caused by anandamide. SN - 0014-2999 UR - https://www.unboundmedicine.com/medline/citation/16472800/Role_of_CGRP_and_GABA_in_the_hypotensive_effect_of_intrathecally_administered_anandamide_to_anesthetized_rats_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0014-2999(05)01329-4 DB - PRIME DP - Unbound Medicine ER -